Mitsubishi Tanabe Pharma will pay 39 for each Neuroderm share, a premium of about 17 percent to its Friday close... READ MORE›
Perhaps that's why Sarepta's executives have claimed in statements that the average price for Exondys 51 is 300,000 per patient per year... READ MORE›
Pamplona will pay 88.10 per share in cash for Parexel, representing a 5 percent premium to the stock's Monday close... READ MORE›
InVentiv, which is equally owned by private equity firms Advent International and Thomas H. Lee Partners, works with larger firms, including the top 20 biopharmaceutical companies... READ MORE›
Daily Digital News provides public access to an archive of historical news articles from many popular news sources. Daily Digital News provides keyword searchable summaries, and links, to news articles that were originally publically accessible, and all news articles presented on dailydigitalnews.com were initially freely available to the general public. Daily Digital News does not claim any copyright ownership of the aggregated content of this website. Aggregated news content presented on dailydigitalnews.com may be subject to copyright, and the use made here is consistent with the principles of limited use for research and education. Daily Digital News takes advantage of unique web-crawling technologies and algorithms. This includes the use of services provided by Alchemy API (by IBM Watson) as well as other open source technologies. Daily Digital News operates this website on a not for profit basis. No income, revenue, remuneration, or profit of any kind has been made as a result of providing this website to the public. Use of this website is at the user's own discretion. Daily Digital News exercises no control over the use made of this website and accepts no liability to users or resources in relation to the contents of, or use of, or otherwise in connection with this website. Full Terms & Conditions